By disrupting the expression of a particular gene and observing how this change affects expression of other genes, researchers can learn about the cellular roles of the disrupted gene. New technologies such as Perturb-seq offer unprecedented detail and depth of insight from such genetic disruption studies, but technical and practical hurdles have limited use of […]
– KAPA HyperExome is a state-of-the-art whole exome research panel with improved performance over the on-market SeqCap portfolio, providing improved coverage and uniformity – The KAPA Target Enrichment portfolio empowers clinical researchers to process more samples successfully while optimizing sequencing efficiency – When linked with KAPA library prep, the portfolio can reduce turnaround time for […]
Aldevron Appoints James Brown, Ph.D. President of Research Grade Nucleic Acids Business Unit FARGO, N.D. — Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President of its Research Grade nucleic acids business unit. Dr. Brown will oversee Aldevron’s strategy to provide plasmids and other nucleic acids […]
UPPSALA, Sweden – Olink today announced the acquisition of Agrisera AB, a Swedish company specializing in polyclonal and monoclonal antibody production. Agrisera offers an extensive collection of primary and secondary antibodies for a broad range of applications, available in various quantities. The acquisition is an important milestone for Olink in its aim to rapidly increase […]
Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separately. This ground breaking combination technology allows researchers to have superior […]
Test deployed on Quanterix’ Ultrasensitive Simoa® platform improves sensitivity and specificity for measuring immune response and seroconversion earlier and with higher resolution Non-exclusive agreement with Brigham and Women’s Hospital licensed technology to conduct serological assay to address unmet needs in the clinical setting, epidemiological studies, and for therapeutic and vaccine development BILLERICA, Mass.– Quanterix Corporation (NASDAQ: QTRX), […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the GMP Cloudz™ Human T Cell Activation Kit. This is the first GMP-grade kit within the Cloudz product line addressing the need for robust, yet safe products within the clinical- and commercial-scale of the Cell and Gene Therapy manufacturing process. The kit contains Cloudz particles, […]
Merck KGaA, Darmstadt, Germany today announced that two of its Life Science business’ CRISPR-assisted genome-editing patents have been allowed in the United States. Technology provides more tools to fight difficult-to-treat diseases Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses Committed to ethical use of genome-editing technology Merck KGaA, Darmstadt, Germany, […]
BRANFORD, Conn. — IsoPlexis, the leader in functional cellular proteomics, today announced the appointment of John Strahley as Chief Financial Officer. As CFO, Mr. Strahley will be responsible for the company’s strategic planning, finance, accounting, investor relations, and treasury functions, among other pivotal roles. “We look forward to welcoming John to IsoPlexis’ executive leadership team,” said Sean Mackay, […]
SHANGHAI, China — Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are joining forces to promote the development and standardization of NGS-based cancer therapy selection in China based on Illumina’s NextSeqTM 550Dx system. In 2015, Illumina’s sequencing technology and Burning Rock’s development and commercial capabilities were for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
